Chad Shear

August 21, 2020 | The Recorder

One key to a successful outcome against generic challengers in a Hatch-Waxman case is a compelling and factual invention story based on evidence that was created in real time—during the drug development and regulatory process, according to Fish & Richardson's Chad Shear and Geoff Biegler.

By Chad Shear and Geoff Biegler

6 minute read

July 20, 2020 | The Recorder

When it comes to patent due diligence, how do you know which experts to pull from the bench and who to leave on the sidelines?

By Chad Shear and Teresa Lavoie

7 minute read

May 29, 2020 | The Recorder

Putting yourself at the threshold of the other door and considering the room from that perspective can provide useful reminders of each side's strategic opportunities and concerns, and ensure that the doors to the deal are kept open.

By Chad Shear and Teresa A. Lavoie

7 minute read